| RS137852518 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, Spastic paraplegia |
| RS137852519 |
L1CAM
|
Health Risk |
Pathogenic |
MASA syndrome, MASA syndrome |
| RS137852520 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, Spastic paraplegia |
| RS137852521 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, L1 syndrome |
| RS137852522 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked hydrocephalus syndrome, MASA syndrome |
| RS137852523 |
L1CAM
|
Health Risk |
Pathogenic |
MASA syndrome, MASA syndrome |
| RS137852524 |
L1CAM
|
Health Risk |
Pathogenic |
MASA syndrome, Spastic paraplegia |
| RS137852525 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, Spastic paraplegia |
| RS137852526 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked complicated corpus callosum dysgenesis, X-linked hydrocephalus syndrome |
| RS137852527 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS137852528 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852529 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852531 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852532 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852533 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852535 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852536 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852537 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852538 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852539 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS137852540 |
PRPS1
|
Health Risk |
Likely pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Inborn genetic diseases |
| RS137852541 |
PRPS1
|
Health Risk |
Likely pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Arts syndrome |
| RS137852542 |
PRPS1
|
Health Risk |
Pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Phosphoribosylpyrophosphate synthetase superactivity |
| RS137852543 |
PRPS1
|
Health Risk |
Pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Phosphoribosylpyrophosphate synthetase superactivity |
| RS137852544 |
PRPS1
|
Health Risk |
Pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Phosphoribosylpyrophosphate synthetase superactivity |
| RS137852545 |
PRPS1
|
Health Risk |
Pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Phosphoribosylpyrophosphate synthetase superactivity |
| RS137852546 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Thyroid cancer |
| RS137852547 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS137852548 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS137852549 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS137852550 |
RPGR
|
Health Risk |
Likely pathogenic |
RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS |
| RS137852551 |
RPGR
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 1, X-linked cone-rod dystrophy 1 |
| RS137852552 |
SHOX
|
Health Risk |
Pathogenic |
SHOX-related short stature, Leri-Weill dyschondrosteosis |
| RS137852553 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS137852554 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS137852555 |
SHOX
|
Health Risk |
Likely pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS137852556 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, SHOX-related disorder |
| RS137852557 |
SHOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Langer mesomelic dysplasia syndrome, Leri-Weill dyschondrosteosis |
| RS137852558 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS137852560 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS137852561 |
SYP
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 96 |
| RS137852562 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS137852563 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852564 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Prostate cancer |
| RS137852565 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS137852566 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852567 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS137852568 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852569 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Kennedy disease |
| RS137852570 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852571 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Prostate cancer, somatic |
| RS137852572 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS137852573 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS137852574 |
AR
|
Health Risk |
Pathogenic |
Hypospadias 1, X-linked |
| RS137852575 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852576 |
AR
|
Health Risk |
Pathogenic |
Androgen insensitivity, partial |
| RS137852577 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS137852578 |
AR
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS137852579 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852580 |
AR
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS137852581 |
AR
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS137852582 |
AR
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS137852584 |
AR
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS137852585 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852586 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852587 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852589 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852590 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS137852591 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Partial androgen insensitivity syndrome, Kennedy disease |
| RS137852592 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Partial androgen insensitivity syndrome, Kennedy disease |
| RS137852593 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Prostate cancer susceptibility, Prostate cancer |
| RS137852594 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS137852595 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS137852596 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852597 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852598 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852599 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS137852600 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS137852601 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS137852602 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency 1, MHC class II deficiency 1 |
| RS137852603 |
MXI1
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS137852604 |
MXI1
|
Health Risk |
Pathogenic |
Neurofibrosarcoma, Neurofibrosarcoma |
| RS137852605 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Pelger-Huët anomaly, Pelger-Huët anomaly |
| RS137852606 |
LBR
|
Health Risk |
Pathogenic |
Pelger-Huët anomaly, Pelger-Huët anomaly |
| RS137852607 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS137852608 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Retinal dystrophy |
| RS137852609 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, ITGB2-related disorder |
| RS137852610 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852611 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852612 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852613 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852614 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852615 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852616 |
ITGB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukocyte adhesion deficiency 1, Inborn genetic diseases |
| RS137852617 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852618 |
ITGB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS137852619 |
SLC1A3
|
Health Risk |
Pathogenic |
Episodic ataxia type 6, Episodic ataxia type 6 |
| RS137852620 |
SLC1A3
|
Health Risk |
Pathogenic |
Episodic ataxia type 6, Episodic ataxia type 6 |
| RS137852621 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy |
| RS137852622 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |